FDA panel recommends limiting Pfizer booster shots to Americans 65 and older, and those at high risk of severe COVID-19

An FDA panel has voted against recommending approval of a booster COVID-19 shot for the general population – disappointing some public health official…

Leave a Reply

Your email address will not be published. Required fields are marked *